Dec 11, 2023
To improve member affordability and accessibility, effective January 1, 2024, Florida Blue will be moving sixteen of the Condition Care brand name insulin medications to the Tier 2 generic level (from Tier 4) on their Care Choices and ValueScriptRx medication formularies. This change will positively impact almost 102,000 members on individual and group policies.
The medications to be moved are:
| INSULIN TYPE | AFFECTED PRESCRIPTION DRUGS |
|---|---|
| Rapid-Acting Insulin | Fiasp, Insulin Aspart, Novolog |
| Short-Acting Insulin | Humulin R 500, Novolin R, Relion R |
| Intermediate-Acting Insulin | Insulin aspart protamine, Novolin N, Novolin 70/30, Novolog Mix 70/30 |
| Long-Acting Insulin | Insulin degludec, Insulin glargine, Lantus, Levemir, Toujeo, Tresiba |
Since this change happened after the filing deadline, it will not be changed in Florida Blue's filings or benefit summaries. However, the new, lower-cost tiering for these drugs will be reflected in their January 2024 medication formulary update.
The change affects the following specific medication formularies used in group plans:
- SimplyBlue: ValueScriptRx, Care Choices
- BlueCare, BlueSelect and BlueOptions: Care Choices, Care Choices HSA
As a reminder, Winn-Dixie and Harveys pharmacies closed effective December 1, 2023, and members' prescriptions were transferred to Walgreens, CVS, or another local pharmacy. Members can pick up their prescriptions from their current (or new) local participating pharmacy, or have them quickly delivered to their home with Amazon Pharmacy.
For more information, contact your Amwins Connect Regional Sales Manager.
